Inhibikase Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sands Capital Life Sciences Pulse Fund II, L.P.(16.3%),Sands Capital Ventures, LLC(16.3%), etc.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more